Your browser doesn't support javascript.
The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study.
Omrani, Ali S; Almaslamani, Muna A; Daghfal, Joanne; Alattar, Rand A; Elgara, Mohamed; Shaar, Shahd H; Ibrahim, Tawheeda B H; Zaqout, Ahmed; Bakdach, Dana; Akkari, Abdelrauof M; Baiou, Anas; Alhariri, Bassem; Elajez, Reem; Husain, Ahmed A M; Badawi, Mohamed N; Abid, Fatma Ben; Abu Jarir, Sulieman H; Abdalla, Shiema; Kaleeckal, Anvar; Choda, Kris; Chinta, Venkateswara R; Sherbash, Mohamed A; Al-Ismail, Khalil; Abukhattab, Mohammed; Ait Hssain, Ali; Coyle, Peter V; Bertollini, Roberto; Frenneaux, Michael P; Alkhal, Abdullatif; Al-Kuwari, Hanan M.
  • Omrani AS; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050. aomrani@hamad.qa.
  • Almaslamani MA; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Daghfal J; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Alattar RA; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Elgara M; Medical Education Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Shaar SH; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Ibrahim TBH; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Zaqout A; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Bakdach D; Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Akkari AM; Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Baiou A; Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Alhariri B; Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Elajez R; Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Husain AAM; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Badawi MN; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Abid FB; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Abu Jarir SH; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Abdalla S; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Kaleeckal A; Business Intelligence Unit, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Choda K; Business Intelligence Unit, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Chinta VR; Business Intelligence Unit, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Sherbash MA; Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Al-Ismail K; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Abukhattab M; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Ait Hssain A; Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Coyle PV; Division of Virology, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Bertollini R; Ministry of Public Health, Doha, Qatar, PO Box 42.
  • Frenneaux MP; Scientific, Academic and Faculty Affairs, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Alkhal A; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Al-Kuwari HM; Ministry of Public Health, Doha, Qatar, PO Box 42.
BMC Infect Dis ; 20(1): 777, 2020 Oct 19.
Article in English | MEDLINE | ID: covidwho-873955
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
Semantic information from SemMedBD (by NLM)
1. COVID-19 PROCESS_OF Patients
Subject
COVID-19
Predicate
PROCESS_OF
Object
Patients
2. CD69 protei ASSOCIATED_WITH C5203670
Subject
CD69 protei
Predicate
ASSOCIATED_WITH
Object
C5203670
3. Hospitals LOCATION_OF Diagnosis
Subject
Hospitals
Predicate
LOCATION_OF
Object
Diagnosis
4. Patient in hospital PROCESS_OF Adult
Subject
Patient in hospital
Predicate
PROCESS_OF
Object
Adult
5. Increased risk COEXISTS_WITH Chronic Kidney Diseases
Subject
Increased risk
Predicate
COEXISTS_WITH
Object
Chronic Kidney Diseases
6. COVID-19 PROCESS_OF Patients
Subject
COVID-19
Predicate
PROCESS_OF
Object
Patients
7. CD69 protein, human|CD69 ASSOCIATED_WITH COVID-19
Subject
CD69 protein, human|CD69
Predicate
ASSOCIATED_WITH
Object
COVID-19
8. Hospitals LOCATION_OF Diagnosis
Subject
Hospitals
Predicate
LOCATION_OF
Object
Diagnosis
9. Patient in hospital PROCESS_OF Adult
Subject
Patient in hospital
Predicate
PROCESS_OF
Object
Adult
10. Increased risk COEXISTS_WITH Chronic Kidney Diseases
Subject
Increased risk
Predicate
COEXISTS_WITH
Object
Chronic Kidney Diseases
ABSTRACT

BACKGROUND:

There are limited data on Coronavirus Disease 2019 (COVID-19) outcomes at a national level, and none after 60 days of follow up. The aim of this study was to describe national, 60-day all-cause mortality associated with COVID-19, and to identify risk factors associated with admission to an intensive care unit (ICU).

METHODS:

This was a retrospective cohort study including the first consecutive 5000 patients with COVID-19 in Qatar who completed 60 days of follow up by June 17, 2020. The primary outcome was all-cause mortality at 60 days after COVID-19 diagnosis. In addition, we explored risk factors for admission to ICU.

RESULTS:

Included patients were diagnosed with COVID-19 between February 28 and April 17, 2020. The majority (4436, 88.7%) were males and the median age was 35 years [interquartile range (IQR) 28-43]. By 60 days after COVID-19 diagnosis, 14 patients (0.28%) had died, 10 (0.2%) were still in hospital, and two (0.04%) were still in ICU. Fatal COVID-19 cases had a median age of 59.5 years (IQR 55.8-68), and were mostly males (13, 92.9%). All included pregnant women (26, 0.5%), children (131, 2.6%), and healthcare workers (135, 2.7%) were alive and not hospitalized at the end of follow up. A total of 1424 patients (28.5%) required hospitalization, out of which 108 (7.6%) were admitted to ICU. Most frequent co-morbidities in hospitalized adults were diabetes (23.2%), and hypertension (20.7%). Multivariable logistic regression showed that older age [adjusted odds ratio (aOR) 1.041, 95% confidence interval (CI) 1.022-1.061 per year increase; P < 0.001], male sex (aOR 4.375, 95% CI 1.964-9.744; P < 0.001), diabetes (aOR 1.698, 95% CI 1.050-2.746; P 0.031), chronic kidney disease (aOR 3.590, 95% CI 1.596-8.079, P 0.002), and higher BMI (aOR 1.067, 95% CI 1.027-1.108 per unit increase; P 0.001), were all independently associated with increased risk of ICU admission.

CONCLUSIONS:

In a relatively younger national cohort with a low co-morbidity burden, COVID-19 was associated with low all-cause mortality. Independent risk factors for ICU admission included older age, male sex, higher BMI, and co-existing diabetes or chronic kidney disease.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections Type of study: Etiology study / Incidence study / Observational study / Prognostic study / Randomized controlled trials / Risk factors Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged / Pregnancy / Young adult Country/Region as subject: Asia Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections Type of study: Etiology study / Incidence study / Observational study / Prognostic study / Randomized controlled trials / Risk factors Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged / Pregnancy / Young adult Country/Region as subject: Asia Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2020 Document Type: Article